Loading...

FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101205 50 µg 38€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101206 500 µg 106€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  2. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  3. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  4. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  5. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  6. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  7. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  8. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  9. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  10. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  11. Banka AL, et al. 2023. Nat Commun. 14:2462. PubMed
  12. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  13. Qin C, et al. 2023. iScience. 26:106588. PubMed
  14. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  15. Xu Y, et al. 2023. J Cancer. 14:1182. PubMed
  16. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  17. Zhang Y, et al. 2023. NPJ Regen Med. 8:28. PubMed
  18. Chen SW, et al. 2023. Methods Mol Biol. 2683:53. PubMed
  19. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  20. Mawambo G, et al. 2023. J Neuroinflammation. 20:145. PubMed
  21. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  22. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  23. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  24. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  25. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  26. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  27. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  28. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  29. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  30. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  31. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  32. Song R, et al. 2022. Immunology. 165:274. PubMed
  33. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  34. He D, et al. 2022. Immunity. 55:159. PubMed
  35. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  36. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  37. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  38. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  39. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  40. Usui-Ouchi A, et al. 2022. Glia. 70:1762. PubMed
  41. Ocaña-Guzman R, et al. 2022. Cells. 11: . PubMed
  42. Li J, et al. 2022. FASEB J. 36:e22400. PubMed
  43. Dong H, et al. 2022. Proc Natl Acad Sci U S A. 119:e2123247119. PubMed
  44. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  45. Komori R, et al. 2022. Int J Mol Sci. 23: . PubMed
  46. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  47. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  48. Xuan FL, et al. 2022. Front Immunol. 13:1005067. PubMed
  49. Foo CX, et al. 2023. Eur Respir J. 61: . PubMed
  50. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  51. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  52. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  53. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  54. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  55. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  56. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  57. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  58. Chen L, et al. 2022. Cancer Immunol Immunother. :. PubMed
  59. Chan L, et al. 2022. Cells. 12: . PubMed
  60. Wang L, et al. 2022. Nutrients. 15: . PubMed
  61. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  62. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  63. Li Y, et al. 2023. Cell Death Dis. 14:28. PubMed
  64. Freitag K, et al. 2023. Commun Biol. 6:40. PubMed
  65. Schmidt AD, et al. 2023. J Invest Dermatol. :. PubMed
  66. Jiang X, et al. 2023. Cell Discov. 9:7. PubMed
  67. Li B, et al. 2023. Nat Commun. 14:489. PubMed
  68. Schick J, et al. 2023. Elife. 12: . PubMed
  69. Zhu X, et al. 2023. Front Immunol. 14:1114802. PubMed
  70. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  71. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  72. Murotomi K, et al. 2022. Exp Biol Med (Maywood). 247:848. PubMed
  73. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  74. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  75. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  76. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  77. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  78. Gaikwad H, et al. 2022. ACS Nano. . PubMed
  79. Rybova J, et al. 2022. J Inherit Metab Dis. 45:1175. PubMed
  80. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  81. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  82. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  83. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  84. Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed
  85. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  86. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  87. Yang Y, et al. 2023. Cancers (Basel). 15:. PubMed
  88. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  89. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  90. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  91. Dona MSI, et al. 2023. Basic Res Cardiol. 118:11. PubMed
  92. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  93. Iguchi A, et al. 2023. iScience. 26:106375. PubMed
  94. Han S, et al. 2023. Int J Mol Sci. 24:. PubMed
  95. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  96. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  97. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  98. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  99. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  100. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  101. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  102. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  103. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  104. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  105. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  106. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  107. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  108. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  109. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  110. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  111. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  112. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  113. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  114. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  115. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  116. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  117. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  118. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  119. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  120. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  121. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  122. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  123. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  124. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  125. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  126. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  127. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  128. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  129. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  130. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  131. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  132. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  133. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  134. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  135. Poli V, et al. 2021. iScience. 24:103256. PubMed
  136. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  137. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  138. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  139. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  140. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  141. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  142. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  143. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  144. Chen S, et al. 2022. Cancer Discov. :. PubMed
  145. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  146. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  147. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  148. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  149. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  150. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  151. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  152. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  153. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  154. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  155. Li B, et al. 2022. iScience. 25:103772. PubMed
  156. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  157. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  158. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  159. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  160. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  161. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  162. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  163. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  164. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  165. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  166. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  167. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  168. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  169. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  170. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  171. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  172. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  173. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  174. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  175. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  176. Kasper M, et al. 2021. Elife. 10:. PubMed
  177. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  178. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  179. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  180. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  181. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  182. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  183. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  184. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  185. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  186. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  187. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  188. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  189. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  190. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  191. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  192. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  193. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  194. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  195. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  196. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  197. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  198. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  199. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  200. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  201. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  202. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  203. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  204. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  205. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  206. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  207. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  208. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  209. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  210. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  211. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  212. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  213. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  214. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  215. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  216. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  217. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  218. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  219. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  220. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  221. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  222. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  223. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  224. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  225. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  226. Gao H, et al. 2021. Cells. 10:. PubMed
  227. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  228. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  229. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  230. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  231. Köchl R, et al. 2020. Elife. 9:00. PubMed
  232. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  233. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  234. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  235. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  236. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  237. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  238. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  239. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  240. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  241. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  242. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  243. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  244. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  245. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  246. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  247. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  248. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  249. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  250. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  251. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  252. Dong S, et al. 2021. Nature. 591:117. PubMed
  253. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  254. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  255. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  256. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  257. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  258. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  259. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  260. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  261. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  262. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  263. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  264. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  265. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  266. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  267. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  268. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  269. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  270. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  271. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  272. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  273. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  274. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  275. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  276. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  277. Cho K, et al. 2021. iScience. 24:103117. PubMed
  278. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  279. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  280. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  281. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  282. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  283. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  284. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  285. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  286. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  287. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  288. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  289. Dong L, et al. 2022. Cells. 11:. PubMed
  290. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  291. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  292. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  293. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  294. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  295. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  296. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  297. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  298. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  299. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  300. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  301. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  302. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  303. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  304. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  305. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  306. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  307. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  308. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  309. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  310. Liu P, et al. 2022. iScience. 25:103867. PubMed
  311. Vasudevan SO, et al. 2022. Cell Rep. 39:110755. PubMed
  312. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  313. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  314. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  315. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  316. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  317. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  318. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  319. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  320. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  321. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  322. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  323. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  324. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  325. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  326. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  327. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  328. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  329. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  330. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  331. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  332. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  333. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  334. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  335. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  336. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  337. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  338. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  339. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  340. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  341. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  342. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  343. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  344. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  345. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  346. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  347. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  348. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  349. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  350. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  351. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  352. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  353. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  354. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  355. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  356. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  357. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  358. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  359. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  360. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  361. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  362. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  363. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  364. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  365. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  366. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  367. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  368. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  369. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  370. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  371. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  372. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  373. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  374. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  375. Tang S, et al. 2022. Virol J. 19:32. PubMed
  376. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  377. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  378. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  379. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  380. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  381. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  382. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  383. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  384. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  385. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  386. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  387. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  388. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  389. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  390. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  391. Wang X, et al. 2022. Elife. 11:. PubMed
  392. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  393. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  394. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  395. Liu SS, et al. 2021. Immunity. :. PubMed
  396. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  397. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  398. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  399. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  400. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  401. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  402. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  403. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  404. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  405. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  406. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  407. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  408. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  409. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  410. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  411. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  412. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  413. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  414. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  415. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  416. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  417. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
  418. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  419. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  420. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  421. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  422. Wang S, et al. 2022. Blood. 140:171. PubMed
  423. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  424. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  425. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  426. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  427. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
  428. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  429. Trivedi S, et al. 2020. Elife. 9:00. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312789 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account